stimates that there are more than
one million people in the U.S. living with HIV/AIDS, with an additional 40,000
people being infected each year. It is estimated that 300,000 infected persons
are unaware of their HIV status. More than 4 million people in the U.S. have
been infected with HCV, 3.2 million of whom are chronically infected. HCV is
the leading cause of liver cancer in the U.S. More than 1,200,000 people are
chronically infected with HBV and about 5,000 people die of complications of
HBV every year in the U.S. Many individuals with HBV and HCV show no symptoms
of disease, and do not know that they are infected.
About Roche Blood Screening
Roche Diagnostics is the leading provider of real-time PCR-based nucleic
acid tests for the international blood bank market. Nucleic acid-based tests
enable earlier detection of active HIV, Hepatitis C, and Hepatitis B
infections than conventional antibody or antigen assays. Roche assays have
been used by the Japanese Red Cross since 1999 to screen Japan's entire blood
supply. Roche launched the automated cobas s 201 system and the cobas
TaqScreen MPX Test outside the United States in 2006 for the most
comprehensive single-assay detection of HIV-1 Groups M & O, HIV-2, and
hepatitis B and C in donated blood and plasma. The West Nile Virus test for
this platform was launched in the U.S. in 2007.
About Roche
Headquartered in Basel, Switzerland, Roche is one of the world's leading
research-focused healthcare groups in the fields of pharmaceuticals and
diagnostics. As the world's biggest biotech company and an innovator of
products and services for the early detection, prevention, diagnosis and
treatment of diseases, the Group contributes on a broad range of fronts to
improving people's health and quality of life. Roche is the world leader in in
vitro diagnostics and drugs for cancer and transplantation, and is a market
leader i
'/>"/>
Page: 1 2 3 Related biology technology :1.
Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait2.
FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania3.
FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox4.
NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program5.
FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia6.
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)7.
FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir8.
FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections9.
FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer10.
FDA Approves Genzymes Renvela(TM) for Dialysis Patients11.
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML